These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6744495)

  • 1. Antivertigo agents. II. Structure-activity relationships of 6-substituted 5,6,7,8-tetrahydro-1,6-naphthyridines.
    Shiozawa A; Ichikawa Y; Ishikawa M; Kogo Y; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):995-1005. PubMed ID: 6744495
    [No Abstract]   [Full Text] [Related]  

  • 2. Antivertigo agents. IV. Synthesis and antivertigo activity of 6-[omega-(4-aryl-1-piperazinyl)alkyl]-5,6,7,8-tetrahydro-1,6-naphth yridines.
    Shiozawa A; Ichikawa Y; Komuro C; Ishikawa M; Furuta Y; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):3981-93. PubMed ID: 6529796
    [No Abstract]   [Full Text] [Related]  

  • 3. Antivertigo agents. V. Quantitative structure-activity relationships of 6-[2-(4-aryl-1-piperazinyl)ethyl]-5,6,7,8-tetrahydro-1,6-naphthyridine s.
    Shiozawa A; Kogo Y; Ichikawa Y; Komuro C; Ishikawa M; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1985 Dec; 33(12):5332-40. PubMed ID: 3833382
    [No Abstract]   [Full Text] [Related]  

  • 4. Antivertigo agents. I. Structure-activity relationships of 2-(2-aminoethyl)pyridines.
    Shiozawa A; Ichikawa Y; Komuro C; Idzu G; Ishikawa M; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):553-63. PubMed ID: 6733806
    [No Abstract]   [Full Text] [Related]  

  • 5. Antivertigo agents. III. Synthesis of 5,6,7,8-tetrahydro-1,6-naphthyridine methyl homologs.
    Shiozawa A; Ichikawa Y; Komuro C; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Jul; 32(7):2522-9. PubMed ID: 6499080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Syntheses of nitrogen-containing heterocyclic compounds. XLIV. Syntheses of 5-substituted 1,6-naphthyridine derivatives using the Reissert compound of 1,6-naphthyridine (author's transl)].
    Hamada Y; Shigemura K
    Yakugaku Zasshi; 1979 Dec; 99(12):1225-8. PubMed ID: 544763
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of gastric acid secretion by 1,8-naphthyridin-2(1H)-ones.
    Bolhofer WA; Hoffman JM; Habecker CN; Pietruszkiewicz AM; Cragoe EJ; Torchiana ML
    J Med Chem; 1979 Mar; 22(3):301-6. PubMed ID: 423213
    [No Abstract]   [Full Text] [Related]  

  • 8. Azaberbene derivatives as alpha 2A-adrenoceptor antagonists.
    Szántay C; Szabó L; Zsilla G; Vizi SE
    Arch Pharm (Weinheim); 2002 Jan; 335(1):22-6. PubMed ID: 11933676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activities of 10-substituted benzo[b][1,5]naphthyridines.
    Sinha BK; Sato RI
    J Pharm Sci; 1978 Mar; 67(3):407-9. PubMed ID: 347048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists.
    Mahesh R; Perumal RV; Pandi PV
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5179-81. PubMed ID: 15380223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in beta-adrenoceptor-blocking activity produced by chemical modifications in the practolol molecule.
    Weinstock M; Schechter Y; Erez M; Shtacher G
    Eur J Pharmacol; 1974 May; 26(2):191-7. PubMed ID: 4152806
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthesis and preliminary pharmacological screening of 2,4-disubstituted N,N-dialkyl-1,8-naphthyridine-3-carboxamides].
    Di Braccio M; Roma G; Balbi A; Sottofattori E; Carazzone M
    Farmaco; 1989 Sep; 44(9):865-81. PubMed ID: 2604838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and binding study on pyrazolo[4,5-c] [1,8]naphthyridines.
    Cecchi L; Colotta V; Filacchioni G; Melani F; Palazzino G; Galli A
    Farmaco Sci; 1987 Sep; 42(9):671-80. PubMed ID: 2826226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of new esters of 2- and 4-alkylamino-1,8-naphthyridine-3-carboxylic acids endowed with positive inotropic properties.
    Heber D; Verborg M; Mohr K
    Arzneimittelforschung; 1994 Jul; 44(7):809-14. PubMed ID: 7945513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives.
    Wang J; Breslin MJ; Coleman PJ; Duggan ME; Hunt CA; Hutchinson JH; Leu CT; Rodan SB; Rodan GA; Duong LT; Hartman GD
    Bioorg Med Chem Lett; 2004 Feb; 14(4):1049-52. PubMed ID: 15013021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Structure-activity relationships of histamine analogues, XX: absolute configuration and histamine-like activity of the enantiomeric alpha-methylhistamines].
    Gerhard G; Schunack W
    Arch Pharm (Weinheim); 1980 Aug; 313(8):709-14. PubMed ID: 7416927
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between circular dichroism data and biological activities of 2,5 substituted enkephalin analogues.
    Soós J; Berzétei I; Bajusz S; Rónai AZ
    Life Sci; 1980 Jul; 27(2):129-33. PubMed ID: 6249995
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of 1,8-naphthyridine derivatives. Potential antihypertensive agents. II.
    Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A
    Farmaco Sci; 1986 Nov; 41(11):827-38. PubMed ID: 2879740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position.
    Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1807-10. PubMed ID: 19217284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of substance P analogs with arginine in position eleven.
    Sofuku S; Torigoe K; Muramatsu I
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4144-8. PubMed ID: 6085034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.